Vanguard Personalized Indexing Management LLC Increases Holdings in Axon Enterprise, Inc $AXON

Vanguard Personalized Indexing Management LLC boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 23.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,471 shares of the biotechnology company’s stock after purchasing an additional 2,730 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Axon Enterprise were worth $8,219,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of AXON. Creative Financial Designs Inc. ADV purchased a new position in Axon Enterprise during the 4th quarter valued at about $28,000. New Millennium Group LLC purchased a new position in Axon Enterprise during the 3rd quarter valued at about $29,000. Sound Income Strategies LLC increased its holdings in Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after purchasing an additional 44 shares during the period. Camelot Portfolios LLC purchased a new position in Axon Enterprise during the 4th quarter valued at about $30,000. Finally, AlphaCentric Advisors LLC purchased a new position in shares of Axon Enterprise during the 4th quarter worth approximately $34,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on AXON. Zacks Research upgraded Axon Enterprise from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 19th. UBS Group reduced their target price on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a report on Thursday, May 7th. Royal Bank Of Canada reduced their target price on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a report on Wednesday, February 25th. Needham & Company LLC reduced their target price on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a report on Friday, February 20th. Finally, The Goldman Sachs Group set a $535.00 target price on Axon Enterprise in a report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $712.75.

Insider Transactions at Axon Enterprise

In other news, CEO Patrick W. Smith sold 20,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total value of $10,000,000.00. Following the sale, the chief executive officer directly owned 3,060,997 shares of the company’s stock, valued at $1,530,498,500. The trade was a 0.65% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Cameron Brooks sold 1,242 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total value of $621,000.00. Following the completion of the sale, the executive directly owned 49,710 shares in the company, valued at approximately $24,855,000. This represents a 2.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 38,989 shares of company stock worth $19,090,083. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON opened at $443.21 on Tuesday. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The business’s 50 day moving average price is $410.95 and its 200-day moving average price is $488.34. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $885.91. The stock has a market cap of $35.72 billion, a P/E ratio of 178.00, a P/E/G ratio of 8.03 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm had revenue of $807.35 million for the quarter, compared to analysts’ expectations of $778.91 million. During the same period in the previous year, the firm posted $1.47 EPS. The business’s revenue for the quarter was up 33.7% compared to the same quarter last year. Equities research analysts anticipate that Axon Enterprise, Inc will post 1.82 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.